Carvedilol
Product Images NDC 60760-376

6 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 60760-376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carv (Carvedilol 60760 376 60)

Carv (Carvedilol 60760 376 60)
Carvedilol Tablets USP 6.25 mg packaging label. The label indicates a quantity of 60 tablets, with NDC 60760-376-60. Manufactured by Beximco Pharmaceuticals Ltd., Tongi, Gazipur, Bangladesh, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes dosage instructions to use as directed and storage conditions to store at controlled room temperature 15°-30°C (59°-86°F). Some lot and expiration information is not specified.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph comparing percent mortality over 21 months between Carvedilol and placebo groups. The x-axis shows time in months, and the y-axis shows percent mortality. The graph indicates lower mortality with Carvedilol compared to placebo, with a p-value of 0.0014 noted.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A forest plot showing hazard ratios across various patient subgroups including sex, age, race, diabetes status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, with all patients combined at the bottom. The horizontal axis represents hazard ratio values from 0.0 to 2.0. Each subgroup has a corresponding dot and confidence interval line indicating the hazard ratio estimate and variability.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph showing mortality percentage over a 24-month period, comparing two groups labeled Placebo and Carvedilol. The graph includes a p-value of 0.03, indicating statistical difference between the groups over time.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A figure showing a forest plot with hazard ratios for various patient subgroups related to heart failure, prior myocardial infarction, medication use, comorbidities, and clinical parameters. The plot includes risk estimates with confidence intervals represented by dots and horizontal lines for each subgroup categorized by factors such as age, sex, prior medication, disease status, Killip classification, and blood pressure levels.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of Carvedilol, showing its molecular framework with multiple aromatic rings and functional groups, including a methoxyphenyl group and a hydroxypropylamine side chain. The structure includes notation for hydroxyl, amine, and ether features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.